Compile Data Set for Download or QSAR
Report error Found 66 of affinity data for UniProtKB/TrEMBL: Q9Z183
TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449871BDBM449871(US10703741, Compound I-14)
Affinity DataIC50: 550nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449859BDBM449859(US10703741, Compound I-2)
Affinity DataIC50: 550nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449861BDBM449861(US10703741, Compound I-9 | US10703741, Compound I-...)
Affinity DataIC50: 550nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449862BDBM449862(US10703741, Compound I-5)
Affinity DataIC50: 550nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528716BDBM528716(US11198681, Compound I-43)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528721BDBM528721(US11198681, Compound I-48)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528723BDBM528723(US11198681, Compound I-50)
Affinity DataIC50: 3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528710BDBM528710(US11198681, Compound I-37)
Affinity DataIC50: 3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528754BDBM528754(US11198681, Compound I-78)
Affinity DataIC50: 3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528711BDBM528711(US11198681, Compound I-38)
Affinity DataIC50: 3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528741BDBM528741(US11198681, Compound I-66)
Affinity DataIC50: 3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528692BDBM528692(US11198681, Compound I-19)
Affinity DataIC50: 3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528712BDBM528712(US11198681, Compound I-39)
Affinity DataIC50: 3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528743BDBM528743(US11198681, Compound I-68)
Affinity DataIC50: 3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528728BDBM528728(US11198681, Compound I-55)
Affinity DataIC50: 3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528744BDBM528744(US11198681, Compound I-69)
Affinity DataIC50: 3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528746BDBM528746(US11198681, Compound I-70)
Affinity DataIC50: 3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528747BDBM528747(US11198681, Compound I-71)
Affinity DataIC50: 3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528701BDBM528701(US11198681, Compound I-28)
Affinity DataIC50: 3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528749BDBM528749(US11198681, Compound I-73)
Affinity DataIC50: 3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528703BDBM528703(US11198681, Compound I-30)
Affinity DataIC50: 3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528737BDBM528737(US11198681, Compound I-62)
Affinity DataIC50: 3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449858BDBM449858(US10703741, Compound I-1)
Affinity DataIC50: 5.50E+3nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528748BDBM528748(US11198681, Compound I-72)
Affinity DataIC50: 7.50E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449865BDBM449865(US10703741, Compound I-8)
Affinity DataIC50: 7.50E+3nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528719BDBM528719(US11198681, Compound I-46)
Affinity DataIC50: 7.50E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528742BDBM528742(US11198681, Compound I-67)
Affinity DataIC50: 7.50E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528693BDBM528693(US11198681, Compound I-20)
Affinity DataIC50: 7.50E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528750BDBM528750(US11198681, Compound I-74)
Affinity DataIC50: 7.50E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528682BDBM528682(US11198681, Compound I-9)
Affinity DataIC50: 7.50E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528705BDBM528705(US11198681, Compound I-32)
Affinity DataIC50: 7.50E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449860BDBM449860(US10703741, Compound I-3)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528722BDBM528722(US11198681, Compound I-49)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528685BDBM528685(US11198681, Compound I-12)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528751BDBM528751(US11198681, Compound I-75)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528752BDBM528752(US11198681, Compound I-76)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528690BDBM528690(US11198681, Compound I-17)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528724BDBM528724(US11198681, Compound I-51)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528753BDBM528753(US11198681, Compound I-77)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528725BDBM528725(US11198681, Compound I-52)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528691BDBM528691(US11198681, Compound I-18)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528726BDBM528726(US11198681, Compound I-53)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528727BDBM528727(US11198681, Compound I-54)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528755BDBM528755(US11198681, Compound I-79)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528694BDBM528694(US11198681, Compound I-21)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528756BDBM528756(US11198681, Compound I-80)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528715BDBM528715(US11198681, Compound I-42)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 449867BDBM449867(US10703741, Compound I-10)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2021
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528717BDBM528717(US11198681, Compound I-44)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Mouse)
Padlock Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 528718BDBM528718(US11198681, Compound I-45)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2022
Entry Details
US Patent

Displayed 1 to 50 (of 66 total ) | Next | Last >>
Jump to: